Summary
Available data indicate that the most common β-lactamase produced by Branhamella catarrhalis is plasmid mediated. The same enzyme occurs in Moraxella nonliquefaciens, a commensal in the upper respiratory tract. The ability to produce the enzyme, which is known as BRO-1, can be transferred by conjugation from M. nonliquefaciens to B. catarrhalis. Since the first β-lactamase-producing strains of B. catarrhalis appeared in 1977, the frequency of β-lactamase production has increased rapidly; figures as high as 76% have been reported. The plasmid-mediated β-lactamase TEM-1 occurs in several species of the genus Haemophilus. While the frequency of β-lactamase production in H. influenzae is reported to be 10–15%, the incidence is significantly higher in non-pathogenic Haemophilus species. Both phenoxymethyl-penicillin and ampicillin promote the occurrence of β-lactamase-producing strains, but the selective pressure exerted by ampicillin seems to be more pronounced. It may be possible to reduce the ecological effects of the penicillins by avoiding overdiagnosis of the most common bacterial infections of the respiratory tract, and by shortening the courses of antibiotic treatment.
Similar content being viewed by others
References
Brook I, Gober AE. Emergence of beta-lactamase producing aerobic and anaerobic bacteria in the oropharynx of children following penicillin chemotherapy. Clinical Pediatrics 23: 338–341, 1984
Brook I, Yocum P. Bacteriology of chronic tonsillitis in young adults. Archives of Otolaryngology 110: 803–805, 1984
Buu Hoi-Dang Van A, Brive-Le Bouguenec C, Barthelemy M, Labia R. Novel beta-lactamase from Branhamella catarrhalis. Annales de Microbiologie 129B: 397–406, 1978
Coffey Jr JD. Otitis media in the practice of pediatrics: bacteriological and clinical observations. Journal of Pediatrics 38: 25–32, 1966
Coffey JD, Martin AD, Booth HN. Neisseria catarrhalis in exudative otitis media. Archives of Otolaryngology 86: 403–406, 1967
Eliasson I, Kamme C. Characterization of the plasm id-mediated beta-lactamase in Branhamella catarrhalis, with special reference to substrate affinity. Journal of Antimicrobial Chemotherapy 15: 139–149, 1985
Eliasson I, Kamme C, Prellner K. Prevalance and transfer of beta-lactamase production in the upper respiratory tract. A study of fifty children undergoing adenoidectomy. In Press, 1985
Freijd AA, Rynnel-Dagöö B. Isolation of nasopharyngeal beta-lactamase producing Haemophilus influenzae, in relation to antibiotic treatment of acute otitis media in infants. Acta Oto-laryngologica 95: 351–357, 1983
Howie VM, Ploussard JH, Lester Jr RL. Otitis media: A clinical and bacteriological correlation. Pediatrics 45: 29–35, 1970
Ingvarsson L. Acute otalgia in children — findings and diagnosis. Acta Paediatrica Scandinavica 71: 705–710, 1982
Ingvarsson L, Lundgren K. Penicillin treatment of acute otitis media in children. A study of the duration of treatment. Acta Oto-Laryngologica 94: 283–287, 1982
Johnson MA, Drew WL, Roberts M. Branhamella (Neisseria) catarrhalis — a lower respiratory tract pathogen? Journal of Clinical Microbiology 13: 1066–1069, 1981
Kamme C. Susceptibility in vitro of Haemophilus influenzae to penicillin G, penicillin V and ampicillin. Incubation of strains from acute otitis media in air and in CO2-atmosphere. Acta Pathologica Microbiologica et Immunologica Scandinavica 75: 611–621, 1969
Kamme C. Evaluation of the in vitro sensitivity of Neisseria catarrhalis to antibiotics with respect to acute otitis media. Scandinavian Journal of Infectious Diseases 2: 117–120, 1970
Kamme C. Microbiology of acute and secretory otitis media. In Treatment of ear nose and throat infections. National Board of Health and Welfare Drug Information Committee, Sweden 1985
Kamme C, Lundgren K, Mardh P-A. The aetiology of acute otitis media in children. Scandinavian Journal of Infectious Diseases 3: 217–223, 1971
Kamme C, Nilsson NI. Secretory otitis media: Microbiology of the middle ear and the nasopharynx. Scandinavian Journal of Infectious Diseases 16: 291–296, 1984
Kamme C, Vang M, Ståhl S. Intrageneric and intergeneric transfer of Branhamella catarrhalis beta-lactamase production. Scandinavian Journal of Infectious Diseases 16: 153–155, 1984
Karma P, Luotonen J, Pukander J, Sipilä M, Herva E, Grönroos P. Haemophilus influenzae in acute otitis media. Acta Otolaryngologica 95: 105–110, 1983
Kovatch AL, Wald RR, Michaels RH. Beta-lactamase-producing Branhamella catarrhalis causing otitis media in children. Journal of Pediatrics 102: 261–264, 1983
Knudsin RB, Miller JM. Significance of the Staphylococcus aureus carrier state in the treatment of disease due to group A streptococci. New England Journal of Medicine 271: 1395–1397, 1964
Laurin L, Prellner K, Kamme C. Phenoxymethylpenicillin and therapeutic failure in acute otitis media. Scandinavian Journal of Infectious Diseases 17: 367–370, 1985
Leinonen M, Luotonen J, Herva E, Valkonen K, Mäkelä PH. Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. Journal of Infectious Diseases 144: 570–574, 1981
Luotonen J, Herva E, Karma P, Timonen M, Leinonen M, Mäkelä PH. The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods. Scandinavian Journal of Infectious Diseases 13: 177–183, 1981
Maddocks JL. Indirect pathogenicity. Journal of Antimicrobial Chemotherapy 6: 307–309, 1980
Malmvall B-E, Brorsson J-E, Johnsson J. In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis. Journal of Antimicrobial Chemotherapy 3: 374–375, 1977
Matthew M, Hedges RW, Smith JT. Types of beta-lactamase determined by plasmids in Gram-negative bacteria. Journal of Bacteriology 138: 657–662, 1979
Ninane G, Joly J, Kraytman M. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture. British Medical Journal 1: 276–278, 1978
Percival A, Corkill JE, Rowlands J, Sykes RB. Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis. Lancet 2: 1175, 1977
Pintado C, Salvador C, Rotger R, Nombela C. Multiresistance plasmid from commensal Neisseria strains. Antimicrobial Agents and Chemotherapy 27: 120–124, 1985
Puhakka H, Virolainen E, Aantaa E. Treatment of acute otitis media in children: Penicillin V or amoxicillin? Acta Otolaryngologica 386 (Suppl.): 108–111, 1982
Qvarnberg Y. Acute otitis media. A prospective clinical study of myringotomy and antimicrobial treatment. Acta Otolaryngologica 375 (Suppl.): 1–157, 1981
Rosenthal SL, Freundlich LF, Gilardi GL, Clodomar FY. In vitro antibiotic sensitivity of Moraxella species. Chemotherapy 24: 360–363, 1978
Schalén L, Christensen P, Kamme C, Miörner H, Pettersson KI, Schalén C. High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scandinavian Journal of Infectious Diseases 12: 277–280, 1980
Schalén L, Christensen P, Eliasson I, Fex S, Kamme C, Schalén C. Inefficacy of penicillin V in acute laryngitis in adults: evaluation from results of double-blind study. Annals of Otology, Rhinology and Laryngology 94: 14–17, 1985
Scheifele DW, Fussell SJ. Ampicillin-resistant Haemophilus influenzae colonizing ambulatory children. American Journal of Diseases of Children 135: 406–409, 1981
Scheifele DW, Fussell SJ, Roberts MC. Characterization of ampicillin-resistant Haemophilus parainfluenzae. Antimicrobial Agents and Chemotherapy 21: 734–739, 1982
Schremer A. Pathogenicity of Branhamella catarrhalis. Acta Oto-laryngologica 407 (Suppl.): 40–42, 1984
Schwartz RH, Rodriguez W, Khan W, et al. The increasing incidence of ampicillin-resistant Haemophilus influenzae. Journal of the American Medical Association 239: 320–323, 1978
Schwartz RH, Rodriguez WJ, Khan WN, Mann R, Barsanti RG, Ross S. Trimethoprim-sulfamethoxazole in the treatment of otitis media caused by ampicillin-resistant strains of Haemophilus influenzae. Rev. Infect. Dis. 4: 514–516, 1982
Shurin PA, Marchant CD, Kim CH, Van Hare GF, Johnson E, et al. Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatric Infectious Disease 2: 34–38, 1983
Srinivasan G, Raff MJ, Templeton WC, Givens SJ, Graves RC, Melo JC. Branhamella catarrhalis pneumonia. Report of two cases and review of the literature. American Review of Respiratory Diseases 123: 553–555, 1981
Syriopoulou V, Scheifele D, Smith AL, Perry P, Howie V. Increasing incidence of ampicillin resistance in Hemophilus influenzae. Journal of Pediatrics 92: 889–892, 1978
Teele D, Pelton S, Klein J. Bacteriology of acute otitis media unresponsive to initial antimicrobial therapy. Journal of Pediatrics 98: 537–539, 1981
Tunér K, Nord CE. Betalactamase-producing microorganisms in recurrent tonsillitis. Scandinavian Journal of Infectious Diseases 39 (Suppl.): 83–85, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eliasson, I., Kamme, C. Upper Respiratory Tract Infections. Drugs 31 (Suppl 3), 116–121 (1986). https://doi.org/10.2165/00003495-198600313-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198600313-00026